Table 1 Participant demographic and clinical characteristics by study
|  | Study 1 N = 71 | Study 2 N = 18 | ||
|---|---|---|---|---|
Characteristic | N | Median (Range) | N | Median (Range) |
Age, years | 71 | 59.0 (36–88) | 18 | 58.5 (32–78) |
| Â | N | % | N | % |
Race | Â | Â | Â | Â |
 Asian | 1 | 1.4 | 0 | 0.0 |
 Black or African American | 0 | 0.0 | 2 | 11.1 |
 White | 65 | 91.6 | 16 | 88.9 |
 More than one race | 1 | 1.4 | 0 | 0.0 |
 Missing | 4 | 5.6 | 0 | 0.0 |
Ethnicity | Â | Â | Â | Â |
 Hispanic or Latino | 1 | 1.4 | 14 | 77.8 |
 Not Hispanic/Latino | 65 | 91.6 | 4 | 22.2 |
 Missing | 5 | 7.0 | 0 | 0.0 |
Cancer Stage | Â | Â | Â | Â |
 I | 10 | 14.1 | 2 | 11.1 |
 II | 7 | 9.9 | 0 | 0.0 |
 III | 34 | 47.9 | 12 | 66.7 |
 IV | 20 | 28.2 | 4 | 22.2 |
Histology | Â | Â | Â | Â |
 High-grade serous | 47 | 66.2 | 12 | 66.7 |
 Low-grade serous | 4 | 5.6 | 1 | 5.6 |
 Mucinous | 3 | 4.2 | 0 | 0.0 |
 Clear cell | 10 | 14.1 | 1 | 5.6 |
 Endometrioid | 6 | 8.5 | 3 | 16.7 |
 Mixed | 1 | 1.4 | 1 | 5.6 |
 Carcinosarcoma | 0 | 0.0 | 1 | 5.6 |
Neoadjuvant chemotherapy | Â | Â | Â | Â |
 No |  |  | 13 | 72.2 |
 Yes |  |  | 5 | 27.8 |